The Role and Mechanism of Incretins in Gynaecologic Diseases
Jiayu Yan, Minyue Cao, Yan Ding, Yiqin Zhang, Yihan Sun, Genyi Jiang, Yanli Zhang, Luyao Kang, Xue Zhou, Jing Luo, Bilan Li · 2026
Read The Role and Mechanism of Incretins in Gynaecologic Diseases by Jiayu Yan, Minyue Cao, Yan Ding, Yiqin Zhang, Yihan Sun, Genyi Jiang, Yanli Zhang, Luyao Kang, Xue Zhou, Jing Luo, Bilan Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13614832.txt.
Description
Jiayu Yan and co-authors present a review dated 2026 on incretin hormones in women's diseases. Incretins are gut hormones, chiefly GLP-1 and GIP, best known for controlling blood sugar. Obesity, a global health problem, is closely tied to several gynecological disorders, including polycystic ovary syndrome and womb cancer.
The authors searched three databases for work from 1995 onward. Evidence shows the hormones also tune inflammation, cell recycling, immune responses, and gut-brain signaling. Drugs that mimic GLP-1 are already common in diabetes and weight care. The review weighs what they might offer for ovary, womb, and related conditions. It sums up mechanisms and treatment promise across the field, based on original studies and major reviews.
Catalog record
| CREATOR | Jiayu Yan, Minyue Cao, Yan Ding, Yiqin Zhang, Yihan Sun, Genyi Jiang, Yanli Zhang, Luyao Kang, Xue Zhou, Jing Luo, Bilan Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |